US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Metsera Inc.

70.50

0.0000

Volume:- -

Turnover:- -

Market Cap:7.43B

PE:-11.96

High:70.50

Open:70.50

Low:70.50

Close:70.50

52wk High:83.86

52wk Low:12.30

Shares:105.38M

Float Shares:64.51M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.8924

EPS(LYR):-14.4907

ROE:-134.66%

ROA:-38.77%

PB:22.03

PE(LYR):-4.87

Loading ...

Overview Company News Filings

Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.

Metsera Inc - Termination Fee Payable by Co Under Some Circumstances Increased to $265 Mln - SEC Filing

THOMSON REUTERS

Metsera falls after accepting up to $10 billion offer from Pfizer

Top Premarket Decliners

MT Newswires Live

Novo Nordisk Stock (NVO) Rises on Plan to Pursue Other Obesity Deals after Metsera Loss

S&P 500 Futures Up In Premarket Trading; Monday.Com, Metsera Lag

Pfizer (PFE.US) Clinches $10 Billion Deal for Metsera (MTSR.US) as Novo Nordisk (NVO.US) Withdraws Bid

North American Morning Briefing: Stock Futures Boosted by Shutdown Hopes

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, CoreWeave, and More -- Barrons.com

U.S. Stocks to Watch: Nvidia, Tesla, Palantir, Metsera, Pfizer, Boeing, CoreWeave, and More

BUZZ-Metsera plunges as bidding war ends with Pfizer securing $10 billion deal

Metsera Shares Fall 15.5% Premarket; Pfizer Wins $10 Bln Bidding War to Acquire Co

THOMSON REUTERS

BUZZ-Metsera bid exit gives boost to Novo Nordisk shares

Pfizer’s Strategic Acquisition of Metsera: Balancing Opportunities and Risks in the Obesity Market

Pfizer Wins $10 Billion Bidding War For Metsera As Novo Nordisk Exits

BREAKINGVIEWS-The Week in Breakingviews: Doing battle over drugs

Novo continues to look for opportunities in obesity, diabetes, Bloomberg says

Pfizer Clinches $10 Billion Metsera Deal as Novo Nordisk Loses Weight-Loss Drug Battle

Novo Nordisk Raises Offer for Metsera to $65.60 Per Share and Will Not Increase Further

Novo Nordisk: Believe That Structure of Our Potential Merger Agreement Is Compliant With Antitrust Laws

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MTSR/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"MTSR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","market":"US","secType":"STK","nameCN":"Metsera Inc.","latestPrice":70.5,"timestamp":1771621200000,"preClose":70.5,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":64513712,"shares":105376189,"eps":-5.892395,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-20 16:00:00 EST","open":70.5,"high":70.5,"low":70.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.892395,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":0,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":70.5,"volumeRatio":0,"impliedVol":0.3139,"impliedVolPercentile":0.2031},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","floatShares":64513712,"roa":"-38.77%","roe":"-134.66%","lyrEps":-14.490661,"shares":105376189,"dividePrice":0,"high":70.5,"amplitude":0,"preClose":70.5,"low":70.5,"week52Low":12.3,"pbRate":"22.03","week52High":83.8599,"institutionHeld":0,"latestPrice":70.5,"eps":-5.892395,"divideRate":0,"volume":0,"delay":0,"ttmEps":-5.892395,"open":70.5,"prevYearClose":70.5,"prevWeekClose":70.5,"prevMonthClose":70.5,"prevQuarterClose":70.5,"fiveDayClose":70.5,"twentyDayClose":70.5,"sixtyDayClose":70.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTSR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"MTSR","reason":null,"defaultRemindTime":1763130600000,"announcedDate":"2025-11-12","type":"delisting","dateTimestamp":1763096400000},{"market":"US","date":"2025-11-12","symbol":"MTSR","fiscalQuarterEnding":"2025/09","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.11},{"market":"US","date":"2025-07-28","symbol":"MTSR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753675200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-05-12","symbol":"MTSR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-03-26","symbol":"MTSR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":-3.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTSR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTSR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1761886800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTSR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTSR","date":"2025-11-14","current":-11.964575,"percent":0.036082,"low":-55.8522,"twenty":-17.976689,"median":-12.456963,"eighty":-10.995731,"high":-6.570442,"avg":-14.489177,"sd":5.001483,"marketCap":7429021324},"quantilePoints":[{"date":"2025-02-07","current":-17.973411,"twenty":-17.939327,"median":-17.8882,"eighty":-17.837073,"marketCap":3042628924},{"date":"2025-02-14","current":-18.277736,"twenty":-18.639274,"median":-18.277736,"eighty":-17.958804,"marketCap":3094146515},{"date":"2025-02-21","current":-19.257661,"twenty":-19.263748,"median":-18.612493,"eighty":-17.973411,"marketCap":3260033158},{"date":"2025-02-28","current":-15.222317,"twenty":-19.263748,"median":-18.292952,"eighty":-17.802989,"marketCap":2576909901},{"date":"2025-03-07","current":-16.749262,"twenty":-19.257661,"median":-17.973411,"eighty":-16.634383,"marketCap":2835398748},{"date":"2025-03-14","current":-15.094245,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":2555229332},{"date":"2025-03-21","current":-17.309229,"twenty":-18.72205,"median":-17.732316,"eighty":-15.847091,"marketCap":2930192911},{"date":"2025-03-28","current":-15.074845,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":3152557072},{"date":"2025-04-04","current":-10.624224,"twenty":-18.709149,"median":-17.433667,"eighty":-15.417782,"marketCap":2221812131},{"date":"2025-04-11","current":-6.570442,"twenty":-18.612493,"median":-16.926585,"eighty":-14.065167,"marketCap":1374056864},{"date":"2025-04-17","current":-8.815846,"twenty":-18.585291,"median":-16.597864,"eighty":-11.231036,"marketCap":1843631343},{"date":"2025-04-25","current":-10.639294,"twenty":-18.362232,"median":-16.039969,"eighty":-10.465489,"marketCap":2224963638},{"date":"2025-05-02","current":-11.734368,"twenty":-18.283822,"median":-15.629326,"eighty":-9.926993,"marketCap":2453973115},{"date":"2025-05-09","current":-12.437626,"twenty":-18.170614,"median":-15.417782,"eighty":-10.4896,"marketCap":2601043422},{"date":"2025-05-16","current":-10.120836,"twenty":-18.143134,"median":-15.084545,"eighty":-9.926993,"marketCap":2690472328},{"date":"2025-05-23","current":-11.083125,"twenty":-18.007321,"median":-13.673351,"eighty":-10.08689,"marketCap":2946282563},{"date":"2025-05-30","current":-10.903313,"twenty":-17.962456,"median":-12.437626,"eighty":-10.237022,"marketCap":2898482293},{"date":"2025-06-06","current":-11.330119,"twenty":-17.863854,"median":-12.078462,"eighty":-10.380871,"marketCap":3011942274},{"date":"2025-06-13","current":-13.665697,"twenty":-17.760585,"median":-12.111113,"eighty":-10.505751,"marketCap":3632820504},{"date":"2025-06-20","current":-10.950736,"twenty":-17.702451,"median":-12.009847,"eighty":-10.478878,"marketCap":2911088957},{"date":"2025-06-27","current":-11.345927,"twenty":-17.568059,"median":-11.719298,"eighty":-10.542899,"marketCap":3016144495},{"date":"2025-07-03","current":-11.638368,"twenty":-17.408779,"median":-11.681839,"eighty":-10.571353,"marketCap":3093885594},{"date":"2025-07-11","current":-14.388896,"twenty":-17.268165,"median":-11.697647,"eighty":-10.619566,"marketCap":3825072138},{"date":"2025-07-18","current":-17.506951,"twenty":-17.303722,"median":-11.789624,"eighty":-10.623027,"marketCap":4653960333},{"date":"2025-07-25","current":-15.67129,"twenty":-17.246135,"median":-12.009847,"eighty":-10.627238,"marketCap":4165977359},{"date":"2025-08-01","current":-11.259046,"twenty":-17.080186,"median":-12.060267,"eighty":-10.669177,"marketCap":3465782198},{"date":"2025-08-08","current":-10.542344,"twenty":-16.963959,"median":-11.907491,"eighty":-10.669177,"marketCap":3245165568},{"date":"2025-08-15","current":-10.340985,"twenty":-16.859629,"median":-11.799396,"eighty":-10.571353,"marketCap":3183182801},{"date":"2025-08-22","current":-11.194202,"twenty":-16.776854,"median":-11.704228,"eighty":-10.619566,"marketCap":3445821646},{"date":"2025-08-29","current":-11.958684,"twenty":-16.726286,"median":-11.700938,"eighty":-10.623027,"marketCap":3681146051},{"date":"2025-09-05","current":-12.385292,"twenty":-16.634383,"median":-11.74414,"eighty":-10.624224,"marketCap":3812465474},{"date":"2025-09-12","current":-12.712928,"twenty":-16.561345,"median":-11.903146,"eighty":-10.627666,"marketCap":3913318790},{"date":"2025-09-19","current":-12.252191,"twenty":-16.438168,"median":-11.874013,"eighty":-10.639294,"marketCap":3771493814},{"date":"2025-09-26","current":-17.959018,"twenty":-16.749262,"median":-11.907491,"eighty":-10.774419,"marketCap":5528180703},{"date":"2025-10-03","current":-17.681988,"twenty":-17.103908,"median":-11.968922,"eighty":-10.788708,"marketCap":5442905015},{"date":"2025-10-10","current":-17.989799,"twenty":-17.506951,"median":-12.044006,"eighty":-10.863794,"marketCap":5537655780},{"date":"2025-10-17","current":-18.078722,"twenty":-17.750391,"median":-12.092917,"eighty":-10.890458,"marketCap":5565028223},{"date":"2025-10-24","current":-18.000059,"twenty":-17.870095,"median":-12.173695,"eighty":-10.903313,"marketCap":5540814139},{"date":"2025-10-31","current":-21.796385,"twenty":-17.928237,"median":-12.282118,"eighty":-10.950736,"marketCap":6709406898},{"date":"2025-11-07","current":-27.891028,"twenty":-17.959018,"median":-12.385292,"eighty":-10.986017,"marketCap":8585472031},{"date":"2025-11-14","current":-24.134147,"twenty":-17.976689,"median":-12.456963,"eighty":-10.995731,"marketCap":7429021324}],"updateTime":1771835719799},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTSR\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582879734","title":"Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879734","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879734?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:05","pubTimestamp":1762779900,"startTime":"0","endTime":"0","summary":"Pfizer is buying its way back into the obesity-drug game after fighting off a rival bid from Novo Nordisk to buy Metsera, with more money and help from the Trump administration. Pfizer won its fight to buy obesity-drug maker Metsera, with an extra $1.7 billion and a little help from the Trump administration.Pfizer Inc. pulled off a comeback win, beating out Danish drug giant Novo Nordisk to acquire obesity drug developer Metsera Inc. in a deal that values the biotechnology company at up to $9.1 billion.Pfizer  wanted it more, as its attempts to develop its own weight-loss drugs failed, and Novo Nordisk  already has Ozempic and Wegovy. So after first refusing to budge on its original deal, even reportedly going as far as suing the other players, Pfizer kicked in $1.7 billion more to win.Pfizer's stock has been struggling to keep up, as demand for its breakthrough COVID vaccine and treatment keeps falling - so it needed to get into the obesity game or risk falling even further behind. Ov","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0097036916.USD","LU1989771016.USD","LU2237443382.USD","IE00B1XK9C88.USD","LU0109391861.USD","LU2023250504.SGD","LU0238689110.USD","LU2089984988.USD","LU2237443895.HKD","BK4516","SGXZ31699556.SGD","LU0198837287.USD","LU0289739699.SGD","LU0256863902.USD","LU2361045086.USD","LU1066051498.USD","LU2491050154.USD","LU2108987350.USD","IE0004445239.USD","LU1366192091.USD","MTSR","LU2357305700.SGD","PFE","LU1066053197.SGD","LU0466842654.USD","IE00BJJMRZ35.SGD","LU2461242641.AUD","LU2468319806.SGD","LU0256863811.USD","GB00BDT5M118.USD","LU0820561909.HKD","LU0058720904.USD","LU1093756325.SGD","LU2237443622.USD","LU1894683348.USD","LU1093756168.USD","LU0323591593.USD","LU2237443978.SGD","LU2491050071.SGD","BK4592","LU1883839398.USD","LU2237443549.SGD","IE00BJT1NW94.SGD","LU1267930730.SGD","LU2063271972.USD","LU0471298694.HKD","LU2491049909.HKD","BK4533"],"gpt_icon":1},{"id":"2582876074","title":"Metsera Inc - Termination Fee Payable by Co Under Some Circumstances Increased to $265 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2582876074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582876074?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:54","pubTimestamp":1762779277,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WM0T8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0985481810.HKD","LU0306806265.USD","LU1057294990.SGD","BK4550","BK4581","LU1066053197.SGD","LU1894683264.USD","BK4533","BK4588","IE0002270589.USD","LU0456855351.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","MTSR","IE00BLSP4239.USD","BK4139","SG9999011175.SGD","SG9999013999.USD","LU0321505439.SGD","LU0868494617.USD","BK4592","BK4599","BK4534","LU1023059063.AUD","BK4007","SG9999002232.USD","IE00B19Z3581.USD","LU0122379950.USD","LU0321505868.SGD","LU1066051498.USD","IE00BBT3K403.USD","SG9999003800.SGD","SG9999001176.SGD","SGXZ57979304.SGD","LU0225284248.USD","BK4568","IE000M9KFDE8.USD","LU0225771236.USD","IE00B19Z3B42.SGD","SG9999001176.USD","LU0170899867.USD","LU0234572021.USD","BK4585","LU1883839398.USD","LU0058720904.USD","PFE","SG9999002224.SGD","LU1894683348.USD","LU0306807586.USD"],"gpt_icon":0},{"id":"2582876049","title":"Metsera falls after accepting up to $10 billion offer from Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2582876049","media":"Reuters","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582876049?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:52","pubTimestamp":1762779171,"startTime":"0","endTime":"0","summary":"UPDATE 3-Metsera falls after accepting up to $10 billion offer from PfizerUpdates shares, adds analyst comment in paragraph 4, CEO comment in paragraph 13By Mariam Sunny","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1310ced763b367f15a56d0feccf44e16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL1N3WM0ED:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU1868837300.USD","LU2237443895.HKD","LU1551013342.USD","LU1868837136.USD","LU2168563687.JPY","SGXZ57979304.SGD","SG9999001176.SGD","LU2237443382.USD","SG9999011175.SGD","IE0002141913.USD","LU2168564222.USD","IE0004445239.USD","LU0985481810.HKD","LU1868836591.USD","LU0640476718.USD","LU0385154629.USD","IE00BKDWB100.SGD","LU0256863811.USD","LU2168564065.EUR","LU2168564149.EUR","LU1983299246.USD","LU0708995401.HKD","LU1064131342.USD","LU1988902786.USD","SG9999015986.USD","IE00BJJMRZ35.SGD","LU0353189763.USD","SG9999001176.USD","IE00B1BXHZ80.USD","LU0306807586.USD","IE00B4R5TH58.HKD","LU0122379950.USD","LU0238689110.USD","LU1917777945.USD","LU2746668461.USD","LU1720051108.HKD","SG9999018865.SGD","SG9999014906.USD","LU2456880835.USD","MTSR","LU1366192091.USD","LU2237443622.USD","LU0234572021.USD","LU2237443978.SGD","PFE","BK4599","LU1868836914.USD","LU2237443549.SGD"],"gpt_icon":1},{"id":"2582876096","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2582876096","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582876096?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:50","pubTimestamp":1762779038,"startTime":"0","endTime":"0","summary":"Monday.com  shares were 19% lower pre-bell Monday following a 4.7% increase in the previous session.Metsera  stock was down 15% after Novo Nordisk  refused to further raise its acquisition bid for the company following a sweetened offer from Pfizer .Centene  shares were 7% lower following a 1.2% gain in the previous session.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","IE00BZ1G4Q59.USD","SG9999013999.USD","LU0154236417.USD","BK4097","LU0130102774.USD","LU2065171311.SGD","SG9999003800.SGD","BK4585","IE00BLSP4452.SGD","LU1894683264.USD","SG9999001176.SGD","LU1720051017.SGD","LU0225771236.USD","LU1291159041.SGD","BK4581","LU1201861249.SGD","IE00B19Z3581.USD","BK4154","LU1201861165.SGD","NVO.AU","CNC","BK4007","IE00BBT3K403.USD","LU0321505439.SGD","SG9999002232.USD","LU2065171402.SGD","LU0130103400.USD","LU0225284248.USD","LU0648000940.SGD","LU0985481810.HKD","BK4599","LU2362540622.SGD","LU0456855351.SGD","BK4550","LU2065169927.USD","LU0122379950.USD","IE0002270589.USD","BK4613","SG9999002224.SGD","LU1023059063.AUD","PFE.AU","IE0034235188.USD","LU1699723380.USD","BK4588","BK4539","MTSR","MNDY"],"gpt_icon":0},{"id":"2582629876","title":"Novo Nordisk Stock (NVO) Rises on Plan to Pursue Other Obesity Deals after Metsera Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2582629876","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582629876?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:35","pubTimestamp":1762778149,"startTime":"0","endTime":"0","summary":"Danish drug giant Novo Nordisk’s shares rose modestly during early trading on Monday. This came after reports that Novo Nordisk’s pursuit of obesit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-rises-on-plan-to-pursue-other-obesity-deals-after-metsera-loss?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-rises-on-plan-to-pursue-other-obesity-deals-after-metsera-loss?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","IE00BZ1G4Q59.USD","BK4007","MTSR","BK4532","LU0154236417.USD","BK4585","NVO","LU1093756325.SGD","IE00BKVL7J92.USD","BK4599","BK4588","BK4139"],"gpt_icon":0},{"id":"2582487668","title":"S&P 500 Futures Up In Premarket Trading; Monday.Com, Metsera Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2582487668","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582487668?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:31","pubTimestamp":1762777860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Maplebear Inc.  was up 8.1% in pre-market trading, and Caris Life Sciences Inc.  was up 7.3%.AngloGold Ashanti PLC , BitMine Immersion Technologies Inc. , and Celestica Inc.  were all posting gains of at least 7%. In early trading, monday.com Ltd.  and Metsera Inc.  had posted declines, falling 17.2% and 14.8%, respectively.Meanwhile S&P 500 futures were up 0.92%, with futures for the Dow Jones Industrial Average rising 0.41%. The Cboe Volatility Index futures were down 0.75%.In commodities news, Brent crude oil futures were up 0.35%, while gold futures were up 2.31%. Bitcoin climbed 1.32% to $105,998.In the previous regular trading session, the S&P 500 and the Dow were up 0.13% and 0.16%, respectively. Stocks in Asia were up overnight, with Japan's NIKKEI 225 Index up 1.26% and China's Shanghai Composite Index rising 0.53%.U.S. stock market","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4550","IVV","LU0345780521.USD","LU2045819591.USD","CAI","LU1861220033.SGD","CART","SH","LU0496367417.USD","LU0368265764.SGD","BK4145","LU0498741114.HKD","OEF","BK4570","LU0498741890.SGD","LU0724618789.USD","LU2065169927.USD","LU2125910500.SGD","LU1223082196.USD","SDS","BK4539","BK4097","LU0055631609.USD","LU1861215975.USD","BK4023","CLS","VOO","BK4581","AU","BK4104","MNDY","BK4534",".SPX","SPXU","UPRO","OEX","SSO","LU1223083913.SGD","BK4522","MESmain","SPY","BK4533","ESmain","BK4585","IE00BMPRXQ63.HKD","BK4113","BK4017","MTSR"],"gpt_icon":1},{"id":"1193152910","title":"Pfizer (PFE.US) Clinches $10 Billion Deal for Metsera (MTSR.US) as Novo Nordisk (NVO.US) Withdraws Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=1193152910","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193152910?lang=en_us&edition=fundamental","pubTime":"2025-11-10 19:32","pubTimestamp":1762774342,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO.US) has decided not to submit a revised acquisition offer in the bidding war for biotech firm Metsera Inc. (MTSR.US), which was ultimately acquired by Pfizer (PFE.US) for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1310ced763b367f15a56d0feccf44e16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","LU0122379950.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4533","IE0002270589.USD","SG9999001176.SGD","SG9999001176.USD","LU0868494617.USD","LU0456855351.SGD","LU1023059063.AUD","BK4568","SG9999002224.SGD","BK4581","LU1093756325.SGD","LU0306807586.USD","LU0170899867.USD","LU0985481810.HKD","LU1883839398.USD","LU0234572021.USD","SG9999013999.USD","IE00B19Z3B42.SGD","BK4599","BK4139","BK4592","BK4534","LU1066053197.SGD","LU1894683348.USD","IE00BLSP4452.SGD","LU1057294990.SGD","IE00BBT3K403.USD","IE00BLSP4239.USD","IE00BZ1G4Q59.USD","LU1066051498.USD","SG9999002232.USD","BK4585","LU0289739699.SGD","LU0225284248.USD","PFE","NVO","LU0225771236.USD","IE000M9KFDE8.USD","BK4588","SG9999003800.SGD","BK4007","LU0321505868.SGD","LU0321505439.SGD","LU1093756168.USD","LU1894683264.USD","MTSR","LU0306806265.USD","LU0058720904.USD","BK4550","SG9999011175.SGD","IE00BKVL7J92.USD","BK4532"],"gpt_icon":1},{"id":"2582827946","title":"North American Morning Briefing: Stock Futures Boosted by Shutdown Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2582827946","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582827946?lang=en_us&edition=fundamental","pubTime":"2025-11-10 18:59","pubTimestamp":1762772340,"startTime":"0","endTime":"0","summary":"Stock futures were climbing Monday with an end to the record-long government shutdown appearing to be in sight.The Senate late Sunday cleared a key hurdle  after Democrats provided just enough votes to advance a measure designed to end the impasse.\"The next 48 hours in Congress should tell us whether this initiative has legs,\" ING said.An end to the impasse should bring a resumption of economic data. Releases due this week include inflation data for October and jobless claims on Thursday, followed by October retail sales and producer prices on Friday.Technology stocks were among the biggest gainers in the premarket rally, but questions over the AI trade continue to swirl.The Nasdaq composite on Friday posted its worst week since Trump launched a trade war  in April, amid concerns about companies overspending and overpromising on AI initiatives.Trump said the \"hundreds of billions of dollars\" paid to health insurers under the Affordable Care Act should go directly to the public. Centene","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"80d8cebbae2e7255de33612d02db063d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","US6M.BOND","LU1066053197.SGD","SG9999002232.USD","SG9999001176.SGD","SG9999001176.USD","IE0002270589.USD","LU0225771236.USD","SG9999003800.SGD","IE00BLSP4239.USD","LU0170899867.USD","BK4585","BK4534","LU0985481810.HKD","US2Y.BOND","US10Y.BOND","BK4592","US12M.BOND","LU1023059063.AUD","LU0058720904.USD","LU1066051498.USD","LU0868494617.USD","BK4107","US7Y.BOND","LU0122379950.USD","BK4117","BK4599","BK4533","LU0456855351.SGD","IE00B19Z3B42.SGD","LU1057294990.SGD","MTSR","BK4568","LU0234572021.USD","BK4588","US30Y.BOND","LU0306807586.USD","IE00BLSP4452.SGD","LU1894683348.USD","BK4139","LU0225284248.USD","US3Y.BOND","PFE","SG9999002224.SGD","BK4007","IE00B19Z3581.USD","AFG","BK4550","US5Y.BOND","LU0321505868.SGD"],"gpt_icon":1},{"id":"2582827800","title":"These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, CoreWeave, and More -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2582827800","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582827800?lang=en_us&edition=fundamental","pubTime":"2025-11-10 18:45","pubTimestamp":1762771500,"startTime":"0","endTime":"0","summary":"Stock futures were rising Monday with investors hopeful that the government shutdown was nearing an end.Metsera dropped 15% to $70.45 in premarket trading after Pfizer agreed to buy the weight-loss drug start-up for up to $86.25 a share. The deal, which could be worth more than $10 billion, has Pfizer paying $65.60 a share in cash for Metsera and a contingent value right entitling holders to additional payments of up to $20.65 a share in cash. Metsera's board said Pfizer's revised bid for the company represents \"the best transaction for shareholders, both from the perspective of value and certainty of closing.\" Pfizer's deal bested Danish drugmaker Novo Nordisk's bid for Metsera, which has a pipeline of weight-loss medicines. Pfizer gained 0.9%, and Novo Nordisk's American depositary receipts rose 1.6%.Visa rose 0.5% and Mastercard added 0.2% after The Wall Street Journal, citing people familiar with the matter, reported the credit-card giants were nearing a settlement with merchants t","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1310ced763b367f15a56d0feccf44e16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDS","PFE","LU0210533765.USD","2NVD.UK","LU1430594728.SGD","BK4515","IE00B5949003.HKD","NVD","BA","LU1868837300.USD","IE00BJJMRY28.SGD","NVDA","SNVD.UK","IE00BJTD4V19.USD","TSLL","TSYW.SI","IE00BFSS7M15.SGD","SG9999004303.SGD","LU0077335932.USD","LU1935042488.USD","CSCO","LU0823417653.USD","IE00B4JS1V06.HKD","LU0882574139.USD","MTSR","LU0109392836.USD","NVD2.UK","NVIW.SI","LU1935042215.USD","SG9999014880.SGD","LU0823434740.USD","LU2065171311.SGD","NVD3.UK","NVDU","NVDS.UK","IE0009356076.USD","3NVD.UK","LU2250418816.HKD","LU2242649171.HKD","IE00BZ199S13.USD","NVDD","NVDX","LU1861127337.USD","LU1914381329.SGD","LU2286300806.USD","BK4581","NVDY"],"gpt_icon":1},{"id":"2582822458","title":"U.S. Stocks to Watch: Nvidia, Tesla, Palantir, Metsera, Pfizer, Boeing, CoreWeave, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2582822458","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582822458?lang=en_us&edition=fundamental","pubTime":"2025-11-10 18:45","pubTimestamp":1762771500,"startTime":"0","endTime":"0","summary":"US stock futures were rising Monday with investors hopeful that the government shutdown was nearing an end.These stocks were poised to make moves Monday:$Nvidia(NVDA)$ jumped 3.6% in the premarket...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BA","IE0002270589.USD","CRWV","IE00B5949003.HKD","PLTR","LU2077746001.SGD","LU1868836914.USD","LU2168564149.EUR","BK4612","LU1496350502.SGD","LU2125909247.SGD","LU0943347566.SGD","LU2092627202.USD","SG9999002224.SGD","BK4567","LU0266013472.USD","IE00B3M56506.USD","NVO","LU1046421795.USD","LU2097344357.USD","LU1934455194.USD","SG9999017495.SGD","LU0127658192.USD","OXY","FDX","TSLA","MA","UPS","V","LU2111349929.HKD","MTSR","LU1035775433.USD","LU2750360641.GBP","LU0861579265.USD","LU0289961442.SGD","LU1983260115.SGD","NVDA","LU2471134879.HKD","LU1992135472.HKD"],"gpt_icon":0},{"id":"2582822620","title":"BUZZ-Metsera plunges as bidding war ends with Pfizer securing $10 billion deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2582822620","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582822620?lang=en_us&edition=fundamental","pubTime":"2025-11-10 18:28","pubTimestamp":1762770493,"startTime":"0","endTime":"0","summary":"BUZZ-Metsera plunges as bidding war ends with Pfizer securing $10 billion deal** Metsera MTSR.O shares plunge 15.7% to $70.12 premarket after a fierce bidding war for the drugmaker ended late on Friday** MTSR accepts Pfizer's PFE.N $10 bln acquisition bid, and co-bidder Novo Nordisk NOVOb.CO said it would exit the race** PFE agrees to pay $86.25/share in cash, a 3.69% upside to Metsera's Friday close** Metsera accepted Pfizer's sweetened offer citing \"unacceptably high legal and regulatory risks\" in Novo's bid** Bernstein says Pfizer's $10 billion valuation is optimistic, requiring $11 billion in revenue by 2040** MTSR shares had surged nearly 60% last week amid bidding war** MTSR shares have climbed more than threefold since their January IPO, while PFE stock is down 7.82% YTD, as of last close  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1310ced763b367f15a56d0feccf44e16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL6N3WM0J5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BLSP4239.USD","LU0225284248.USD","SG9999011175.SGD","SGXZ57979304.SGD","BK4568","BK4599","IE00B19Z3581.USD","PFE","BK4139","LU0289739699.SGD","SG9999013999.USD","IE00BBT3K403.USD","BK4534","LU0321505868.SGD","BK4007","BK4533","LU1023059063.AUD","IE00BLSP4452.SGD","BK4585","SG9999002232.USD","LU0225771236.USD","BK4550","LU0122379950.USD","LU1057294990.SGD","SG9999001176.SGD","LU0306806265.USD","LU1066051498.USD","LU0456855351.SGD","LU0170899867.USD","LU0321505439.SGD","LU0306807586.USD","BK4592","LU1066053197.SGD","SG9999003800.SGD","LU0985481810.HKD","BK4581","LU1883839398.USD","LU1894683264.USD","LU1894683348.USD","LU0234572021.USD","LU0868494617.USD","IE000M9KFDE8.USD","SG9999001176.USD","MTSR","LU0058720904.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","IE0002270589.USD"],"gpt_icon":1},{"id":"2582261788","title":"Metsera Shares Fall 15.5% Premarket; Pfizer Wins $10 Bln Bidding War to Acquire Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2582261788","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582261788?lang=en_us&edition=fundamental","pubTime":"2025-11-10 17:06","pubTimestamp":1762765596,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1310ced763b367f15a56d0feccf44e16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL4N3WM0LY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MTSR"],"gpt_icon":0},{"id":"2582233998","title":"BUZZ-Metsera bid exit gives boost to Novo Nordisk shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2582233998","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582233998?lang=en_us&edition=fundamental","pubTime":"2025-11-10 16:17","pubTimestamp":1762762664,"startTime":"0","endTime":"0","summary":"BUZZ-Metsera bid exit gives boost to Novo Nordisk shares** Shares in Denmark's Novo Nordisk NOVOb.CO rise around 3% after it dropped its bid for obesity drug developer Metsera MTSR.O ** Metsera accepted the offer from Pfizer PFE.N late on Friday, while Novo said on Saturday it would not be making an increased offer and said it would exit the race ** \"Metsera is out of sight for investors, and it sounds more negative than it probably is,\" Nordnet analyst Per Hansen says  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL8N3WM0A7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU1883839398.USD","IE00BLSP4452.SGD","LU0985481810.HKD","SG9999011175.SGD","LU0321505868.SGD","LU0058720904.USD","LU0306806265.USD","IE00BLSP4239.USD","LU0234572021.USD","BK4533","LU0122379950.USD","LU0321505439.SGD","BK4568","SGXZ57979304.SGD","BK4534","SG9999002224.SGD","LU0456855351.SGD","LU1057294990.SGD","BK4007","BK4588","SG9999003800.SGD","SG9999002232.USD","LU0170899867.USD","SG9999001176.USD","LU0225284248.USD","LU1894683264.USD","BK4585","LU0289739699.SGD","BK4581","BK4550","LU0225771236.USD","LU0868494617.USD","LU1894683348.USD","SG9999013999.USD","LU1066051498.USD","LU1023059063.AUD","MTSR","IE000M9KFDE8.USD","IE0002270589.USD","BK4592","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4139","IE00BBT3K403.USD","LU1066053197.SGD","IE00B19Z3581.USD","BK4599"],"gpt_icon":1},{"id":"2582109148","title":"Pfizer’s Strategic Acquisition of Metsera: Balancing Opportunities and Risks in the Obesity Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2582109148","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582109148?lang=en_us&edition=fundamental","pubTime":"2025-11-10 10:06","pubTimestamp":1762740392,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Chris Schott has maintained their neutral stance on PFE stock, giving a Hold rating on November 6. Chris Schott has given his H...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/pfizers-strategic-acquisition-of-metsera-balancing-opportunities-and-risks-in-the-obesity-market-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/pfizers-strategic-acquisition-of-metsera-balancing-opportunities-and-risks-in-the-obesity-market-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2347655156.SGD","LU0314104364.USD","LU1732800096.USD","LU1244550494.USD","LU1023059063.AUD","MTSR","LU2023251221.USD","BK4599","LU0912757837.SGD","LU0158827781.USD","BK4581","BK4585","LU2357305700.SGD","IE0002270589.USD","LU0225771236.USD","LU0098860793.USD","LU0306806265.USD","BK4127","LU1066051498.USD","LU1732799900.SGD","LU1989772923.USD","BK4504","LU0795875169.SGD","LU1720051108.HKD","SG9999002232.USD","LU0306807586.USD","LU1894683348.USD","LU0106831901.USD","PFE","IE00BLSP4239.USD","LU0234570918.USD","LU0456855351.SGD","SG9999002224.SGD","LU2028103732.USD","BK4588","BK4007","LU2089284900.SGD","LU1883839398.USD","SG9999001176.USD","LU0158827948.USD","LU0320765646.SGD","BK4533","LU1363072403.SGD","LU1720051017.SGD","BK4516","LU0868494617.USD","LU1989772840.SGD","LU0170899867.USD","LU0985481810.HKD","SG9999013999.USD"],"gpt_icon":0},{"id":"2581340853","title":"Pfizer Wins $10 Billion Bidding War For Metsera As Novo Nordisk Exits","url":"https://stock-news.laohu8.com/highlight/detail?id=2581340853","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581340853?lang=en_us&edition=fundamental","pubTime":"2025-11-10 09:53","pubTimestamp":1762739623,"startTime":"0","endTime":"0","summary":"UPDATE 7-Pfizer seals $10 billion deal for Metsera as Novo Nordisk exits raceMetsera's drugs projected to reach $5 billion in peak salesBidding turned into a legal battle over the last weekMerger...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1310ced763b367f15a56d0feccf44e16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251108:nL6N3WK00B:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Pfizer Wins $10 Billion Bidding War For Metsera As Novo Nordisk Exits","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4550","LU1023059063.AUD","PFE","BK4599","MTSR","SG9999001176.USD","LU0868494617.USD","IE00B19Z3581.USD","BK4007","IE00BLSP4239.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU0225771236.USD","LU0058720904.USD","IE00BBT3K403.USD","SG9999003800.SGD","LU0321505439.SGD","SG9999002224.SGD","LU0225284248.USD","LU0234572021.USD","NVO","LU1894683264.USD","SG9999001176.SGD","LU0985481810.HKD","LU1894683348.USD","IE000M9KFDE8.USD","LU0170899867.USD","SG9999002232.USD","LU1883839398.USD","BK4581","LU0306807586.USD","LU0456855351.SGD","SG9999011175.SGD","LU1066051498.USD","BK4568","SG9999013999.USD","BK4534","LU0289739699.SGD","LU1057294990.SGD","LU0122379950.USD","SGXZ57979304.SGD","LU1066053197.SGD","BK4533","IE0002270589.USD","IE00BLSP4452.SGD","BK4585","BK4592","BK4588","LU0306806265.USD"],"gpt_icon":1},{"id":"2582781904","title":"BREAKINGVIEWS-The Week in Breakingviews: Doing battle over drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2582781904","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582781904?lang=en_us&edition=fundamental","pubTime":"2025-11-10 07:45","pubTimestamp":1762731900,"startTime":"0","endTime":"0","summary":"BREAKINGVIEWS-The Week in Breakingviews: Doing battle over drugsThe author is a Reuters Breakingviews columnist. The opinions expressed are his own.By Peter Thal Larsen. For the first time in a while, the U.S. stock market is falling. The S&P 500 Index has shed 4% from its peak on October 29, while the tech-heavy Nasdaq Composite Index is down 6%. Is this a temporary blip, or the beginning of a bigger correction?Email me with your thoughts. If someone forwarded you this newsletter, sign up here to receive it every Saturday.OPENING LINE“It’s the question that just won’t go away among mining bankers and investors: could Rio Tinto RIO.L gatecrash Anglo American’s AAL.L nil-premium offer for $21 billion Canadian miner Teck Resources TECKb.TO?”Read more: Rio can dig up trouble for Anglo’s Teck deal.FIVE THINGS I LEARNED FROM BREAKINGVIEWS THIS WEEKChinese carmakers’ sales in Europe increased 94% in the year to August.The number of countries adopting fiscal rules doubled to 122 between 2000 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251109:nL6N3WL01A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029864427.USD","SG9999014914.USD","LU0965508806.USD","LU1015430645.USD","NVD2.UK","NVDS.UK","LU2065171402.SGD","LU2360032135.SGD","MTSR","RIO.UK","SG9999011175.SGD","IE00B1BXHZ80.USD","LU1280957306.USD","RIO.AU","LU1642822529.SGD","NVDU","LU0265550359.USD","2NVD.UK","NVDX","LU2089283258.USD","AAL.UK","NVDD","LU2463028550.USD","LU2430703251.USD","NVD","LU0308772762.SGD","LU2272731865.HKD","LU0640476718.USD","SG9999014559.SGD","LU2092937148.SGD","SNVD.UK","NVDS","NVDY","NVD3.UK","LU1066051498.USD","LU0979878070.USD","LU0306806265.USD","LU1551013425.SGD","LU2433249047.HKD","LU1951198990.SGD","LU1435385759.SGD","LU0075056555.USD","LU1066053197.SGD","3NVD.UK","LU2505996509.AUD","NVIW.SI","ITV.UK","PFE"],"gpt_icon":1},{"id":"2582281548","title":"Novo continues to look for opportunities in obesity, diabetes, Bloomberg says","url":"https://stock-news.laohu8.com/highlight/detail?id=2582281548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582281548?lang=en_us&edition=fundamental","pubTime":"2025-11-10 04:55","pubTimestamp":1762721715,"startTime":"0","endTime":"0","summary":"While Novo Nordisk (NVO) may have lost Metsera (MTSR) to Pfizer (PFE), CEO Mike Doustdar doesn’t plan to give up on dealmaking any time soon, Eric ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-continues-to-look-for-opportunities-in-obesity-diabetes-bloomberg-says-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-continues-to-look-for-opportunities-in-obesity-diabetes-bloomberg-says-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1894683264.USD","LU0122379950.USD","IE000M9KFDE8.USD","LU0868494617.USD","LU1093756325.SGD","BK4585","LU0456855351.SGD","BK4550","IE00BLSP4239.USD","SG9999002224.SGD","BK4592","LU1883839398.USD","BK4532","LU1023059063.AUD","LU1093756168.USD","LU1066051498.USD","LU1894683348.USD","BK4534","LU0321505439.SGD","IE00BLSP4452.SGD","LU0985481810.HKD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4533","LU0321505868.SGD","LU0234572021.USD","NVO","SG9999001176.SGD","LU0058720904.USD","BK4007","BK4581","LU0170899867.USD","SG9999002232.USD","LU0154236417.USD","MTSR","LU0306806265.USD","IE0002270589.USD","BK4599","SG9999013999.USD","BK4139","IE00BBT3K403.USD","LU1066053197.SGD","LU0225771236.USD","SG9999011175.SGD","LU0306807586.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","SG9999003800.SGD","LU0225284248.USD"],"gpt_icon":0},{"id":"2582919638","title":"Pfizer Clinches $10 Billion Metsera Deal as Novo Nordisk Loses Weight-Loss Drug Battle","url":"https://stock-news.laohu8.com/highlight/detail?id=2582919638","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582919638?lang=en_us&edition=fundamental","pubTime":"2025-11-09 18:29","pubTimestamp":1762684147,"startTime":"0","endTime":"0","summary":"Pfizer ($PFE) has reached a deal to buy Metsera ($MTSR), a weight-loss drug startup, in a transaction that could total more than $10 billion. The a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/pfizer-clinches-10-billion-metsera-deal-as-novo-nordisk-loses-weight-loss-drug-battle?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/pfizer-clinches-10-billion-metsera-deal-as-novo-nordisk-loses-weight-loss-drug-battle?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU0154236417.USD","SG9999003800.SGD","BK4585","LU0225284248.USD","LU0225771236.USD","LU0289739699.SGD","IE00BLSP4452.SGD","LU0868494617.USD","LU1894683264.USD","SGXZ57979304.SGD","MTSR","LU1093756168.USD","LU1093756325.SGD","BK4599","LU0306807586.USD","LU0170899867.USD","LU1894683348.USD","BK4532","BK4534","NVO","SG9999001176.USD","LU0321505868.SGD","SG9999013999.USD","IE00B19Z3581.USD","LU1023059063.AUD","BK4568","LU1066053197.SGD","PFE","LU1057294990.SGD","LU1883839398.USD","IE000M9KFDE8.USD","IE00BZ1G4Q59.USD","LU0122379950.USD","BK4588","LU1066051498.USD","SG9999001176.SGD","LU0985481810.HKD","SG9999002232.USD","BK4007","IE0002270589.USD","LU0321505439.SGD","LU0456855351.SGD","IE00BBT3K403.USD","BK4139","BK4550","LU0058720904.USD","IE00BLSP4239.USD","SG9999002224.SGD","BK4592"],"gpt_icon":0},{"id":"2581852888","title":"Novo Nordisk Raises Offer for Metsera to $65.60 Per Share and Will Not Increase Further","url":"https://stock-news.laohu8.com/highlight/detail?id=2581852888","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581852888?lang=en_us&edition=fundamental","pubTime":"2025-11-08 16:19","pubTimestamp":1762589968,"startTime":"0","endTime":"0","summary":"Novo Nordisk has submitted a revised unsolicited proposal to acquire Metsera, offering $65.60 per share in cash, which equates to an approximate aggregated equity value of $7.6 billion and an enterprise value of about $7.1 billion. The proposal also includes contingent value rights for up to $20.65 per share in cash, dependent on the achievement of certain clinical and regulatory milestones, with a total potential value of up to $2.4 billion. Following a competitive process and further consideration, Novo Nordisk has stated it will not increase its offer for Metsera.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novo Nordisk A/S published the original content used to generate this news brief via GlobeNewswire  on November 08, 2025, an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1310ced763b367f15a56d0feccf44e16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251108:nNDL7f8V60:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","MTSR","LU2095319765.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","NDAQ","IE00B64PRP62.GBP","BK4112","IE00BGHQF748.EUR","LU2210149790.SGD","LU0314104364.USD","BK4585"],"gpt_icon":1},{"id":"2581540448","title":"Novo Nordisk: Believe That Structure of Our Potential Merger Agreement Is Compliant With Antitrust Laws","url":"https://stock-news.laohu8.com/highlight/detail?id=2581540448","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581540448?lang=en_us&edition=fundamental","pubTime":"2025-11-08 16:18","pubTimestamp":1762589938,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251108:nTUABQQ1PX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","SG9999002224.SGD","BK4585","IE00B19Z3581.USD","PFE","LU0321505439.SGD","BK4581","BK4592","BK4568","LU1066051498.USD","LU0306807586.USD","SG9999003800.SGD","SG9999013999.USD","IE00BLSP4239.USD","LU0868494617.USD","IE00BLSP4452.SGD","LU0985481810.HKD","SG9999002232.USD","LU0289739699.SGD","BK4007","LU1894683264.USD","MTSR","BK4599","LU0058720904.USD","LU0234572021.USD","LU1057294990.SGD","SG9999001176.USD","SG9999011175.SGD","SGXZ57979304.SGD","LU0456855351.SGD","SG9999001176.SGD","LU1883839398.USD","LU0170899867.USD","LU1066053197.SGD","BK4534","BK4550","LU0225284248.USD","LU1894683348.USD","LU0122379950.USD","BK4533","BK4588","LU0306806265.USD","BK4139","IE00BBT3K403.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","IE0002270589.USD","LU0225771236.USD","IE000M9KFDE8.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":199,"code":"91000000","status":"200"}]}}